Role of early cell-free DNA levels decrease as a predictive marker of fatal outcome after severe traumatic brain injury

Clinica Chimica Acta

Volumn 414, Issue , 2012, Pages 12-17

  Macher, Hada ^a   Egea Guerrero, Juan J ^a   Revuelto Rey, Jaume ^a   Gordillo Escobar, Elena ^a   Enamorado Enamorado, Judy ^a   Boza, Antonio ^a   Rodriguez, Ana ^a   Molinero, Patrocinio ^a   Guerrero, Juan M ^a   Dominguez Roldán, José Ma ^a   Murillo Cabezas, Francisco ^a   Rubio, Amalia ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Cell free DNA; Prognostic marker; Real time PCR; Traumatic brain injury

Indexed keywords

BIOLOGICAL MARKER; DNA;

ADULT; APACHE; ARTICLE; CELL FREE DNA LEVEL; CELL LEVEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA DETERMINATION; EARLY DIAGNOSIS; FACE INJURY; FATALITY; FEMALE; FOLLOW UP; GENE FUNCTION; GLASGOW COMA SCALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INJURY SCALE; INTENSIVE CARE UNIT; LIMB INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SURVIVAL; THORAX INJURY; TRAUMATIC BRAIN INJURY; BLOOD; BRAIN INJURY; GENETICS; MORTALITY; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE;

ADULT; BIOLOGICAL MARKERS; BRAIN INJURIES; DNA; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 84865310601     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.08.001     Document Type: Article

References (39)

1. Balestreri, M., Czosnyka, M., Chatfield, D.A., et al. Predictive value of Glasgow Coma Scale after brain trauma: change in trend over the past ten years. J Neurol Neurosurg Psychiatry 75 (2004), 161–162.
2. Ghajar, J., Traumatic brain injury. J Emerg Med 356 (2000), 923–929.
3. Faden, A.L., Neuroprotection and traumatic brain injury: theoretical option or realistic proposition. Curr Opin Neurol 15 (2002), 707–712.
4. Duff, D., Altered states of consciousness, theories of recovery and assessment following a severe traumatic brain injury. Axone 23 (2003), 18–23.
5. Herrmann, M., Curio, N., Jost, S., et al. Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury. J Neurol Neurosurg Psychiatry 70 (2001), 95–100.
6. Zemlan, F.P., Jauch, E.C., Mulchahey, J.J., et al. C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome. Brain Res 947 (2002), 131–139.
7. Kleindienst, A., Hesse, F., Bullock, M.R., Buchfelder, M., The neurotrophic protein S100B: value as a marker of brain damage and possible therapeutic implications. Prog Brain Res 161 (2007), 317–325.
8. Shore, P.M., Berger, R.P., Varma, S., et al. Cerebrospinal fluid biomarkers versus Glasgow coma scale and Glasgow outcome scale in pediatric traumatic brain injury: the role of young age and inflicted injury. J Neurotrauma 24 (2007), 75–86.
9. da Rocha, A.B., Zanoni, C., de Freitas, G.R., et al. Serum Hsp70 as an early predictor of fatal outcome after severe traumatic brain injury in males. J Neurotrauma 22 (2005), 966–977.
10. da Rocha, A.B., Schneider, R.F., de Freitas, G.R., et al. Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males. Clin Chem Lab Med 44 (2006), 1234–1242.
11. Murillo-Cabezas, F., Muñoz-Sánchez, M.A., Rincón-Ferrari, M.D., et al. The prognostic value of the temporal course of S100beta protein in post-acute severe brain injury: a prospective and observational study. Brain Inj 24 (2010), 609–619.
12. Egea-Guerrero, J.J., Revuelto-Rey, J., Murillo-Cabezas, F., et al. Accuracy of the S100β protein as a marker of brain damage in traumatic brain injury. Brain Inj 26 (2012), 76–82.
13. Van der Vaart, M., Pretorius, P.J., Circulating DNA. Its origin and fluctuation. Ann N Y Acad Sci 1137 (2008), 18–26.
14. Gahan, P.B., Anker, P., Stroun, M., Metabolic DNA as the origin of spontaneously released DNA?. Ann N Y Acad Sci 1137 (2008), 7–17.
15. Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J.J., Lötvall, J.O., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9 (2007), 654–659.
16. Holdenrieder, S., Stieber, P., Clinical use of circulating nucleosomes. Crit Rev Clin Lab Sci 46 (2009), 1–24.
17. Gahan, P.B., Stroun, M., The virtosome—a novel cytosolic informative entity and intercellular messenger. Cell Biochem Funct 28 (2010), 529–538.
18. Mandel, P., Metais, P., Les acides nucleiques du plasma sanguin chez l'Homme. C R Acad Sci Paris 142 (1948), 241–243.
19. Leon, S.A., Shapiro, B., Sklaroff, D.M., Yaros, M.J., Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37 (1977), 646–650.
20. Lo, Y.M., Corbetta, N., Chamberlain, P.F., et al. Presence of fetal DNA in maternal plasma and serum. Lancet 350 (1997), 485–487.
21. Rainer, T.H., Plasma DNA, prediction and post-traumatic complications. Clin Chim Acta 3132 (2001), 81–85.
22. Rainer, T.H., Wong, L.K., Lam, W., et al. Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem 49 (2003), 562–569.
23. Tong, Y.K., Lo, Y.M., Diagnostic developments involving cell-free (circulating) nucleic acids. Clin Chim Acta 363 (2006), 187–196.
24. Palomaki, G.E., Kloza, E.M., Lambert-Messerlian, G.M., et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 13 (2011), 913–920.
25. Papasavva, T., Kalikas, I., Kyrri, A., Kleanthous, M., Arrayed primer extension for the noninvasive prenatal diagnosis of beta-thalassemia based on detection of single nucleotide polymorphisms. Ann N Y Acad Sci 1137 (2008), 302–308.
26. Macher, H.C., Noguerol, P., Medrano-Campillo, P., et al. Standardization non-invasive fetal RHD and SRY determination into clinical routine using a new multiplex RT-PCR assay for fetal cell-free DNA in pregnant women plasma: results in clinical benefits and cost saving. Clin Chim Acta 413 (2012), 490–494.
27. Butt, A.N., Swaminathan, R., Overview of circulating nucleic acids in plasma/serum. Update on potential prognostic and diagnostic value in diseases excluding fetal medicine and oncology. Ann N Y Acad Sci 1137 (2008), 236–242.
28. Saukkonen, K., Lakkisto, P., Pettilä V., et al., Finnsepsis Study Group. Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock. Clin Chem 54 (2008), 1000–1007.
29. Arnalich, F., Menéndez, M., Lagos, V., et al. Prognostic value of cell-free plasma DNA in patients with cardiac arrest outside the hospital: an observational cohort study. Crit Care, 14, 2010, R47.
30. Wijeratne, S., Butt, A., Burns, S., Sherwood, K., Boyd, O., Swaminathan, R., Cell-free plasma DNA as a prognostic marker in intensive treatment unit patients. Ann N Y Acad Sci 1022 (2004), 323–328.
31. Lo, Y.M., Rainer, T.H., Chan, L.Y., Hjelm, N.M., Cocks, R.A., Plasma DNA as a prognostic marker in trauma patients. Clin Chem 46 (2000), 319–323.
32. Lam, N.Y., Rainer, T.H., Chan, L.Y., Joynt, G.M., Lo, Y.M., Time course of early and late changes in plasma DNA in trauma patients. Clin Chem 49 (2003), 1286–1291.
33. Campello Yurgel, V., Ikuta, N., Brondani da Rocha, A., et al. Role of plasma DNA as a predictive marker of fatal outcome following severe head injury in males. J Neurotrauma 24 (2007), 1172–1181.
34. Raabe, A., Kopetsch, O., Woszczyk, A., et al. S100B protein as a molecular marker in severe traumatic brain injury. Restor Neurol Neurosci 21 (2003), 159–169.
35. Baker, S.P., O'Neill, B., Haddon, W. Jr., Long, W.B., The Injury Severity Score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 14 (1974), 187–196.
36. Navratil, O., Smrcka, M., Hanak, P., The outcome, working ability and psychic changes after traumatic brain injury. Bratisl Lek Listy 107 (2006), 110–112.
37. Leone, M., Albanèse, J., Rousseau, S., et al. Pulmonary contusion in severe head trauma patient: impact on gas exchange and outcome. Chest 124 (2003), 2261–2266.
38. Ghajar, J., Traumatic brain injury. Lancet 356 (2000), 923–929.
39. Ohayon, S., Boyko, M., Saadet, A., et al. Cell-free DNA as a marker for prediction of brain damage in traumatic brain injury in rats. J Neurotrauma 29 (2012), 261–267.